Factors influencing long-term survival in mesothelioma patients—results of the German mesothelioma register

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Archives of Occupational and Environmental Health

• Publication date

  2004-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S00420-003-0498-6PMID 14991330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice.

  2015cited by this paper
• Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

  2003cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• Hyperthermia and mafosfamide in a human-derived malignant pleural mesothelioma cell line

  2002cited by this paper
• Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival

  2002cited by this paper
• Diffuse malignant mesothelioma of the pleural space and its management.

  2002cited by this paper
• Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.

  2002cited by this paper
• The emerging role of antifolates in the treatment of malignant pleural mesothelioma.

  2002cited by this paper
• Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.

  2002cited by this paper
• Current therapy for malignant mesothelioma

  2002cited by this paper
• Treatment of Malignant Mesothelioma

  2001cited by this paper
• Malignant mesothelioma – German mesothelioma register 1987–1999

  2001influential reference
• Prognostic value of FDG PET imaging in malignant pleural mesothelioma.

  2000cited by this paper
• Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

  2000influential reference
• Malignant mesothelioma of the pleural space.

  2000cited by this paper
• Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus

  2000cited by this paper
• Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men.

  2000cited by this paper
• Phase II study of vinorelbine in patients with malignant pleural mesothelioma.

  2000cited by this paper
• Mesotheliom der Pleura und des Peritoneums Diagnostische und therapeutische Folgerungen

  2000cited by this paper
• Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicate.

  2000cited by this paper
• Occupation and risk of malignant pleural mesothelioma: A case-control study in Spain.

  2000cited by this paper
• [Mesothelioma of the pleura and peritoneum. Diagnostic and therapeutic sequelae].

  2000cited by this paper
• Malignancies involving the pericardium.

  2000cited by this paper
• Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

  1999cited by this paper
• [Peritoneal mesothelioma--incidence and etiology].

  1999cited by this paper
• Prognostic value of FDG PET imaging in malignant pleural mesothelioma.

  1999cited by this paper
• Peritoneale Mesotheliome – Häufigkeiten und Ätiologie

  1999cited by this paper
• The European mesothelioma epidemic

  1999cited by this paper
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

  1999influential reference
• A review of chemotherapy trials for malignant mesothelioma.

  1998cited by this paper
• Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant Mesothelioma

  1998cited by this paper
• Prognosis in malignant mesothelioma related to MIB 1 proliferation index and histological subtype.

  1998cited by this paper
• Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.

  1998cited by this paper
• Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma.

  1997cited by this paper
• EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.

  1997cited by this paper
• Routes of asbestos exposure and the development of mesothelioma in an English region.

  1997cited by this paper
• Latency periods in asbestos-related mesothelioma of the pleura.

  1997cited by this paper
• Malignant mesothelioma in south east England: clinicopathological experience of 272 cases.

  1997cited by this paper
• Malignant mesothelioma in women.

  1997cited by this paper
• [Mesothelioma. Pathology/pathogenesis/mesothelioma register].

  1997cited by this paper
• Natural history and epidemiology of malignant mesothelioma.

  1993cited by this paper
• Latent period for malignant mesothelioma of occupational origin.

  1992cited by this paper
• [Pleural mesothelioma: etiology and practical consequences].

  1991cited by this paper
• Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

  1989cited by this paper
• Asbestos-related diseases.

  1989cited by this paper
• Malignant mesothelioma of the pleura.

  1988cited by this paper
• Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.

  1988cited by this paper
• Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.

  1988cited by this paper
• Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases

  1986influential reference
• Malignant mesothelioma 1982: review of 4710 published cases.

  1983influential reference
• Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites.

  1983cited by this paper
• Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.

  1982cited by this paper
• Malignant mesothelioma of the pleura: Review of 123 patients

  1982cited by this paper
• The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health.

  1982cited by this paper
• Malignant peritoneal mesothelioma: review of 25 patients.

  1981cited by this paper
• [Occupational mesotheliomas in West Germany].

  1980cited by this paper
• Malignant mesothelioma in North America

  1980cited by this paper
• The clinical aspects of mesothelioma.

  1976cited by this paper
• Diffuse Malignant Mesothelioma of the Pleura1

  1965cited by this paper
• Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province

  1960cited by this paper

• Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma

  2025cites this paper
• Long-term survival in peritoneal mesothelioma treated with 24 consecutive PIPACs

  2025cites this paper
• The Western Australian Mesothelioma Registry: Analysis of 60 years of cases

  2023cites this paper
• Malignant pleural mesothelioma characteristics and outcomes: A SEER‐Medicare analysis

  2023cites this paper
• Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools

  2023cites this paper
• Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration

  2022cites this paper
• Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma

  2021cites this paper
• The association between pleural fluid exposure and survival in pleural mesothelioma.

  2021cites this paper
• Gender Differences in Outcomes of Patients With Mesothelioma

  2020cites this paper
• Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics

  2020cites this paper
• Identification of Cancer - Mesothelioma Disease Using Logistic Regression and Association Rule

  2018cites this paper
• Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors

  2018cites this paper
• Malignant pleural mesothelioma : recognising an unmet need

  2018cites this paper
• Malignant Pleural Mesothelioma in Young People

  2017cites this paper
• Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis.

  2017cites this paper
• Clinical staging of malignant pleural mesothelioma: current perspectives

  2017cites this paper
• The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database.

  2017cites this paper
• Sarcomatoid Mesothelioma: Future Advances in Diagnosis, Biomolecular Assessment, and Therapeutic Options in a Poor-Outcome Disease

  2016cites this paper
• Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States

  2016influential citation
• A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis

  2016cites this paper
• The hedgehog pathway on malignant mesothelioma

  2015cites this paper
• Spontaneous regression of malignant pleural mesothelioma: A case report

  2015cites this paper
• Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma

  2015cites this paper
• The effect of chemotherapy on health-related quality of life in mesothelioma: results from the SWAMP trial

  2015cites this paper
• Supplementary Prognostic Variables for Pleural Mesothelioma

  2014cites this paper
• Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.

  2014cites this paper
• Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma.

  2013cites this paper
• Lung-sparing total pleurectomy: the surgical option of choice in malignant pleural mesothelioma?

  2013cites this paper
• Regionale Versorgung des malignen Pleuramesothelioms

  2013cites this paper
• Prognostic factors for malignant pleural mesothelioma

  2013cites this paper
• Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

  2013cites this paper
• Biomarkers and prognostic factors for mesothelioma.

  2012cites this paper
• [Malignant pleural mesothelioma].

  2012cites this paper
• The ticking time-bomb of asbestos: its insidious role in the development of malignant mesothelioma.

  2012cites this paper
• Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos

  2011cites this paper
• Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic.

  2011cites this paper
• Factors that Impact Susceptibility to Fiber-Induced Health Effects

  2011cites this paper
• Prognostic Factors for 100 Patients With Malignant Pleural Mesothelioma

  2010cites this paper
• A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters

  2010cites this paper
• Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos.

  2010cites this paper
• Parameters Incorporating Quantitative FDG-PET Imaging with Clinical A Novel Prognostic Model for Malignant Mesothelioma

  2010cites this paper
• Peritoneales Mesotheliom - ein seltener Tumor der Bauchhöhle

  2009cites this paper
• Peritoneales Mesotheliom – ein seltener Tumor der Bauchhöhle

  2009cites this paper
• Differential Expression of Ki-67 and Sex Steroid Hormone Receptors Between Genders in Peritoneal Mesothelioma

  2009cites this paper
• Predicting survival in malignant mesothelioma

  2009cites this paper
• Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.

  2008influential citation
• Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal Mesothelioma

  2008cites this paper
• Prolonged survival due to spontaneous regression and surgical excision of malignant mesothelioma.

  2007cites this paper
• Incidence and Descriptive Epidemiology of Mesothelioma in the United States, 1999–2002

  2007cites this paper
• Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study

  2006cites this paper
• Efficacy of a combination of pemetrexed and multiple redo-surgery in an 11-year-old girl with a recurrent multifocal abdominal mesothelioma.

  2006cites this paper
• Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988–2000: a population-based study

  2005influential citation
• [Severe right-ventricular heart failure due to malignant pericardial mesothelioma].

  2005cites this paper
• Prognostic factors in mesothelioma.

  2005cites this paper
• Prognostic factors in mesothelioma.

  2002cites this paper